NCT07852585Completed
Comparison of Pregnancy Outcomes in Primigravida Receiving Low-Dose Aspirin for the Prevention of Preeclampsia.
Low-Dose Aspirin: A Game-Changer in Preventing Pre-Eclampsia and Adverse Pregnancy Outcomes in Primigravida
Source: ClinicalTrials.gov · Last updated 1 Oct 2026
Brief summary (registry, in English)
Local data on the effectiveness of low-dose aspirin in high-risk primigravida are limited. The present study was planned to compare pregnancy outcomes between high-risk primigravida receiving low-dose aspirin (75 mg/day) from 12 weeks of gestation and those not receiving aspirin.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 160 (actual)
- First submitted
- 25 Sept 2026
- Start date
- 1 Aug 2025
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Muhammad Aamir Latif
- NCT number
- NCT07852585
What you commit to
- Study type: Interventional
- Participants enrolled: 160
- From 1 Aug 2025 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those using aspirin or other antiplatelet drugs
Other illness
- Women with pre-existing chronic hypertension
- Renal disease
- Diabetes mellitus
- Autoimmune disease
- Bleeding disorders
- Hypersensitivity to aspirin
- History of peptic ulcer disease
Who the study is looking for
- Primigravida women
- High-risk pregnancy
- Aged 18-40 years
- Singleton pregnancy
- Gestational age ≤12 weeks
Age in the registry: 18 years to 40 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bahawal Victoria Hospital/Quaid-e-Azam Medical College Coordinator of this site? Confirm its status | Bahawalpur | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.